Keystone Heart

Related Content

The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke. #TCT #TCT2020 #TCTconnect
News | Heart Valve Technology
Keystone Heart TAVR Embolic Protection Device Did Not Demonstrate Superiority 

October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart ...

Home October 15, 2020
arrow
PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices
PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device

April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an ...

Home April 11, 2017
arrow
Videos | Heart Valve Technology
VIDEO: Defining the Need for TAVR Embolic Protection

Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...

Home November 08, 2016
arrow
TAVR, post-procedure, brain lesions, delirium, TCT 2016, Peter R. Stella
News | Heart Valve Technology
Delirium Significantly Associated With Brain Lesions in Patients Post-TAVR

November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics ...

Home November 07, 2016
arrow
Keystone Heart, TriGuard Embolic Protection Device, Neuro-TAVR study, brain lesions, American Journal of Cardiology
News | Heart Valve Technology
Study Shows New Brain Lesions in 94 Percent of Patients Following TAVR

October 3, 2016 — Keystone Heart Ltd. announced data recently published in the American Journal of Cardiology ...

Home October 03, 2016
arrow
Keystone Heart, TriGuard Embolic Protection Device, real-world results, PCR London Valves Conference 2016
News | Embolic Protection Devices
TriGuard Cerebral Protection Device Demonstrates Safety, Efficacy During TAVR Procedures

September 29, 2016 — Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral Embolic ...

Home September 29, 2016
arrow
TriGuard, Keystone, embolic protection, TAVR
Feature
Benefits Seen for First of its Kind Neuro-embolic Protection Shield for TAVR

March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve ...

Home March 19, 2015
arrow
Claret Medical, Sentinel
Feature | Dave Fornell
TAVR Embolic Protection Systems to Reduce Stroke Rates

While transcatheter aortic valve replacement (TAVR) is a paradigm shift in how valve disease is treated, one nagging ...

Home October 02, 2014
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now